We've now fallen behind even India and Korea. This state of affairs exists in large part because of the small scale of our manufacturing operations. When a medication goes out of patent and becomes available as a generic, it becomes far less profitable to make and major firms typically cede its manufacture to smaller drug makers.
「學名藥」我們走了這麼久，卻一直沒辦法做全球競爭，目前更落後在印度、韓國之下，很重要的原因是，我們的生產規模太小了。